Structures by: Kalkhambkar R. G.
Total: 10
N-(2-Chloroquinolin-3-ylmethylene)aniline
C16H11ClN2
Acta Crystallographica Section E (2008) 64, 1 o258-o258
a=6.0069(3)Å b=11.6812(6)Å c=18.3798(9)Å
α=90.00° β=90.00° γ=90.00°
1-(2-Azidoacetyl)-3-methyl-2,6-diphenylpiperidin-4-one
C20H20N4O2
Acta Crystallographica Section E (2010) 66, 11 o2733
a=11.0418(3)Å b=15.7844(5)Å c=10.5684(3)Å
α=90.00° β=108.458(2)° γ=90.00°
Ethyl 4-(3-bromophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C14H15BrN2O3
Acta Crystallographica Section E (2010) 66, 12 o3325
a=12.5184(11)Å b=7.3412(5)Å c=17.0426(15)Å
α=90.00° β=115.086(6)° γ=90.00°
(<i>Z</i>)-2-[2-(4-Methylbenzylidene)hydrazinyl]pyridine
C13H13N3
Acta Crystallographica Section E (2011) 67, 1 o178
a=5.2385(8)Å b=10.7215(17)Å c=20.590(3)Å
α=90.00° β=92.699(5)° γ=90.00°
8-[(Hydrazinylidene)methyl]-4-methyl-2-oxo-2<i>H</i>-chromen-7-yl 4-methylbenzenesulfonate
C18H16N2O5S
Acta Crystallographica Section E (2011) 67, 2 o323
a=9.1947(3)Å b=16.1867(4)Å c=11.6538(3)Å
α=90.00° β=99.6700(10)° γ=90.00°
8-Formyl-4-methyl-2-oxo-2<i>H</i>-chromen-7-yl 4-methylbenzenesulfonate
C18H14O6S
Acta Crystallographica Section E (2011) 67, 6 o1513
a=17.6174(7)Å b=7.2025(3)Å c=25.7706(10)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-Ethyl 2-cyano-3-(1<i>H</i>-pyrrol-2-yl)acrylate
C10H10N2O2
Acta Crystallographica Section E (2011) 67, 8 o2135
a=6.2811(2)Å b=9.4698(3)Å c=16.3936(5)Å
α=90.00° β=92.645(3)° γ=90.00°
1-(3,5-Dichlorophenyl)-1<i>H</i>-1,2,3,4-tetrazole
C7H4Cl2N4
Acta Crystallographica Section E (2012) 68, 2 o433
a=3.8362(2)Å b=9.0524(3)Å c=24.8876(11)Å
α=90.00° β=91.956(4)° γ=90.00°
(<i>E</i>)-Ethyl 2-cyano-3-(furan-2-yl)acrylate
C10H9NO3
Acta Crystallographica Section E (2012) 68, 5 o1482
a=4.6611(2)Å b=19.8907(9)Å c=20.9081(9)Å
α=90.00° β=91.988(4)° γ=90.00°
(<i>Z</i>)-Ethyl 2-cyano-3-(1<i>H</i>-imidazol-2-yl)acrylate
C9H9N3O2
Acta Crystallographica Section E (2013) 69, 8 o1223
a=10.0768(7)Å b=12.0387(8)Å c=7.7047(6)Å
α=90.00° β=90.00° γ=90.00°